Showing results (231-240 of 258) with videos related to
Sort By:
Pageof 26
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2018
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysisBenjamin H Kann, Joseph A Miccio, John M Stahl, et al.Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patientsFrank C Detterbeck, Vincent J Mase, Andrew X Li, et al.Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablationHenry S Park, Frank C Detterbeck, David C Madoff, et al.JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.Clinical Lung Cancer|April 15, 2018
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of ImmunotherapyNavika D Shukla, Ameen A Salahudeen, Gregory A Taylor, et al.Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-makingFrank C Detterbeck, Justin D Blasberg, Gavitt A Woodard, et al.Journal of Thoracic Disease|July 11, 2022
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBrett C Bade, Justin D Blasberg, Vincent J Mase, et al.Cell Reports. Medicine|January 19, 2024
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potentialAnouk M D Becker, Annika H Decker, Georgina Flórez-Grau, et al.Scientific Reports|September 21, 2018
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural NetworksBenjamin H Kann, Sanjay Aneja, Gokoulakrichenane V Loganadane, et al.Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situWesley J Talcott, Joseph A Miccio, Henry S Park, et al.Pageof 26